ONTTF / Oxford Nanopore gets £70m investment from French in-vitro diagnostics partner

Oxford Nanopore Technologies PLC (LSE:ONT) has secured a £70 million investment from French in-vitro diagnostics (IVD) company bioMérieux, in exchan more_horizontal

Oxford Nanopore Technologies PLC (LSE:ONT) analysts are still doubtful about the DNA sequencing company's medium-term guidance despite narrowing fu more_horizontal

Oxford Nanopore Technologies PLC (LSE:ONT) has announced significant breakthroughs in its nanopore sequencing technology at the annual London Calling more_horizontal

Oxford Nanopore Technologies PLC (LSE:ONT) reported a solid increase in full-year revenue driven by growth in its Life Science Research Tools (LSRT) a more_horizontal

Oxford Nanopore is well-positioned to take advantage of the growing demand for DNA sequencing services and capture a growing share of the market. The more_horizontal

Oxford Nanopore Technologies PLC (LSE:ONT) said it appointed former Ocado Group PLC (LSE:OCDO) chief financial officer Duncan Tatton-Brown as its non- more_horizontal

Oxford Nanopore Technologies PLC (LSE:ONT) has reached an amicable resolution to its dispute with the Department of Health and Social Care (DHSC). DHS more_horizontal

Oxford Nanopore Technologies Limited (ONTTF) CEO Gordon Sanghera on Q4 2021 Results - Earnings Call Transcript more_horizontal